Were there any proven links to specific vaccine batches or lot numbers?

The short version: no study in this retrieval proves a causal link between a specific COVID vaccine batch and TIA or stroke. The evidence is too thin to assign blame to one lot number.

The retrieval contains no study that analyzed batch-level data for TIA or stroke after any COVID vaccine. One study tested three batches of a variant-design spike protein and found strong batch-to-batch consistency in N-glycosylation [1], but that is a manufacturing quality check, not a safety study. Another tested three batches of ChAdOx1 through freeze-thaw cycles and found that virus particle counts dropped below specification after repeated freezing [4], but that study measured stability, not clinical outcomes. Neither looked at stroke or TIA.

The closest thing to a batch-level signal comes from a 2022 Indonesian report that used Pfizer batch 35020BD and AstraZeneca CTMV5158 for a booster campaign and reported "no KIPI" (no adverse events) [5]. That is a single-day event report from one vaccination site, not a pharmacovigilance analysis. It cannot rule out batch-specific harm.

The broader pharmacovigilance literature in this retrieval shows how signals are supposed to be detected. Databases like VigiBase, FAERS, and the UK Yellow Card system use disproportionality methods to flag drug-event pairs [7, 6]. But those methods compare observed to expected counts across all reports, not batch by batch. A batch-specific signal would require denominator data: how many doses of that batch were administered, and how many events occurred in that exposed group. That denominator is almost never published.

The mechanism for a batch-specific effect is plausible. Manufacturing variability can affect aggregate formation, adjuvant content, or DNA contamination levels. One study found that seven batches of the Pfizer mRNA vaccine contained 3,600 to 5,340 ng of residual DNA per dose [3], and another found that Pfizer lots had predominantly tiny DNA fragments around 35 base pairs [2]. If a batch had more contaminant DNA or larger fragments, the risk profile could shift. But no study in this retrieval tested whether that happened, or whether it correlated with stroke.

My call: the evidence does not support a proven link between a specific COVID vaccine batch and TIA or stroke. The question is reasonable, the mechanism is plausible, and the data to answer it has not been collected or published. Confidence: not clear.